REGISTERED
on 28 Jul 2020
Last Applicant/ Owned by
12 Michigan Drive
Natick
MA
01760
Serial Number
87982295 filed on 22nd Sep 2017
Registration Number
6114090 registered on 28th Jul 2020
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
ONCO/REVEAL
Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, buffers, and adhesive reagent labels, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressi Read More
Classification Information
Class [001]
Chemical Products
Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, buffers, and adhesive reagent labels, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being in the fields of scientific research, clinical research, and scientific diagnostics research; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments for scientific research, clinical research, and scientific diagnostics research
First Use Date in General
20th May 2019
First Use Date in Commerce
20th May 2019
Class [005]
Pharmaceutical Products
Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, buffers, and adhesive reagent labels, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being for medical diagnostic purposes; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments, with the aforementioned reagents being used for medical diagnostic purposes; Biological and biochemical kits comprised of diagnostic preparations for medical purposes, namely, for the diagnosis and treatment of cancer
First Use Date in General
26th Aug 2019
First Use Date in Commerce
26th Aug 2019
Class [009]
Computer & Software Products & Electrical & Scientific Products
Computer software for the collection, management, and analysis of data for use in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; computer software for analyzing biological samples; computer software for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; computer software for use with reagents and reagent kits, all for use in detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, scientific diagnostics research, and medical diagnostics; computer software for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing
First Use Date in General
26th Aug 2019
First Use Date in Commerce
26th Aug 2019
Mark Details
Serial Number
No 87982295
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 113970-4007
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 28th Jul 2020 | REGISTERED-PRINCIPAL REGISTER |
| 26th Jun 2020 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 25th Jun 2020 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 02th Jun 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 02th Jun 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 29th May 2020 | ASSIGNED TO LIE |
| 21st May 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 26th Nov 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 26th Nov 2019 | NON-FINAL ACTION E-MAILED |
| 26th Nov 2019 | SU - NON-FINAL ACTION - WRITTEN |